Silibinin inhibits expression of HIF-1α through suppression of protein
translation in prostate cancer cells
- Affiliated Author(s)
- 박종욱; 이성용; 장병철; 서성일; 서민호; 백원기
- Alternative Author(s)
- Park, Jong Wook; Lee, Seong Ryong; Jang, Byeong Churl; Suh, Seong Il; Suh, Min Ho; Baek, Won Ki
- Journal Title
- Biochemical and Biophysical Research Communications
- Issued Date
- Silibinin is a polyphenolic flavonoid isolated from the milk thistle (Silybum marianum) and is reported to exhibit anticancer properties. Recently, it has been reported that silibinin inhibits hypoxia-inducible factor-1α (HIF-1α) expression in cancer cells. However, the precise mechanism by which silibinin decreases HIF-1 expression is not fully understood. In this study, silibinin inhibited basal and hypoxia induced expression levels of HIF-1α protein in LNCaP and PC-3 prostate cancer cells, while the rate of HIF-1α protein degradation and mRNA levels were not affected. We found that the decrease in HIF-1 protein by silibinin correlated with suppression of de novo synthesis of HIF-1α protein. Silibinin inhibited global protein synthesis coincided with reduction of eIF4F complex formation and induction of phosphorylation of the translation initiation factor 2α (eIF-2α) which can cause inhibition of general protein synthesis. These results suggest that silibinin’s activity to inhibit HIF-1α protein expression is associated with the suppression of global protein translation.
- Authorize & License
- Files in This Item:
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.